Correlation Between Dermata Therapeutics and Biohaven Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Biohaven Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Biohaven Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Biohaven Pharmaceutical Holding, you can compare the effects of market volatilities on Dermata Therapeutics and Biohaven Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Biohaven Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Biohaven Pharmaceutical.
Diversification Opportunities for Dermata Therapeutics and Biohaven Pharmaceutical
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dermata and Biohaven is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Biohaven Pharmaceutical Holdin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biohaven Pharmaceutical and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Biohaven Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biohaven Pharmaceutical has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Biohaven Pharmaceutical go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Biohaven Pharmaceutical
Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the Biohaven Pharmaceutical. In addition to that, Dermata Therapeutics is 2.5 times more volatile than Biohaven Pharmaceutical Holding. It trades about -0.03 of its total potential returns per unit of risk. Biohaven Pharmaceutical Holding is currently generating about 0.07 per unit of volatility. If you would invest 1,571 in Biohaven Pharmaceutical Holding on September 4, 2024 and sell it today you would earn a total of 3,030 from holding Biohaven Pharmaceutical Holding or generate 192.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Dermata Therapeutics vs. Biohaven Pharmaceutical Holdin
Performance |
| Timeline |
| Dermata Therapeutics |
| Biohaven Pharmaceutical |
Dermata Therapeutics and Biohaven Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Biohaven Pharmaceutical
The main advantage of trading using opposite Dermata Therapeutics and Biohaven Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Biohaven Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will offset losses from the drop in Biohaven Pharmaceutical's long position.| Dermata Therapeutics vs. Candel Therapeutics | Dermata Therapeutics vs. Cingulate Warrants | Dermata Therapeutics vs. Unicycive Therapeutics | Dermata Therapeutics vs. Quoin Pharmaceuticals Ltd |
| Biohaven Pharmaceutical vs. Immunome | Biohaven Pharmaceutical vs. Inhibrx | Biohaven Pharmaceutical vs. Day One Biopharmaceuticals | Biohaven Pharmaceutical vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |